Back to Journals » OncoTargets and Therapy » Volume 13

Overexpression of ERβ Participates in the Progression of Liver Cancer via Inhibiting the Notch Signaling Pathway [Retraction]

Authors Zhang Y, Yi B, Zhou X, Wu Y, Wang L

Received 30 June 2020

Accepted for publication 30 June 2020

Published 16 July 2020 Volume 2020:13 Pages 6849—6850

DOI https://doi.org/10.2147/OTT.S270080

Download Article [PDF] 

Zhang Y, Yi B, Zhou X, Wu Y, Wang L. Onco Targets Ther. 2019;12:8715–8724.


The Editor and Publisher of Onco Targets and Therapy wish to retract the published article.


We were notified of potential image manipulation in the published article. The issues relate to images shown in Figure 1A, which appear to be duplicated with an image used for Figure 1A from another paper by the same authors published in Pathology – Research and Practice:


Zhang Y, Zhou X, Yin C, Wu Y, Wang L. Overexpression of ERβ inhibits the proliferation through regulating TNG-β signaling pathway in osteosarcoma. Pathol Res Pract. 2019;215(10):152568 (https://www.sciencedirect.com/science/article/abs/pii/S0344033819307836?via%3Dihub).


Our other concerns relate to the alleged duplication of images shown in Figures 3C, 3D, 4A and 6A. Despite repeated attempts to contact the authors, they have not responded to our queries within the required  imeframe. The editor determined the findings of the study were no longer valid and requested for the article to be retracted.


Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.


The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]